It is also worth noting that in vitro studies have demonstrated that insulin acts as a growth-stimulating factor for prostate epithelial cells, and its elevated levels are associated with a higher risk of both the development and recurrence of prostate cancer. This evidence concerns the gene INS and prostate carcinoma.